Showing 241 - 260 results of 383 for search '"human immunodeficiency virus"', query time: 0.06s Refine Results
  1. 241

    Endocervical adenocarcinomas and HPV genotyping in an HIV endemic milieu – a retrospective study by Lucília Lovane, Gabriella Lillsunde Larsson, Satish Tulsidás, Carla Carrilho, Sören Andersson, Christina Karlsson

    Published 2025-01-01
    “…Methods Forty consecutive cases of endocervical adenocarcinoma diagnosed at Maputo Central Hospital between 2017 and 2018, with limited clinical data available, were included. Human immunodeficiency virus (HIV) status was determined through serological data or in situ hybridisation on histopathological slides. …”
    Get full text
    Article
  2. 242

    Modeling TB and HIV co-infections by Lih-Ing W. Roeger, Z. Feng, Carlos Castillo-Chávez

    Published 2009-08-01
    “…Tuberculosis (TB) is the leading cause of death among individuals infected with the human immunodeficiency virus (HIV). The study of the joint dynamics of HIV and TB present formidable mathematical challenges due to the fact that the models of transmission are quite distinct. …”
    Get full text
    Article
  3. 243

    Acute Liver Failure among Patients on Efavirenz-Based Antiretroviral Therapy by Innocent Lule Segamwenge, Miriam Kaunanele Bernard

    Published 2018-01-01
    “…We report a series of 4 patients with human immunodeficiency virus (HIV) infection who were admitted with acute liver failure (ALF) over a 6-month period. …”
    Get full text
    Article
  4. 244

    Serum Lipid and Glycemic Profile in HARRT-Naïve and HARRT-Exposed HIV Patients in Enugu State, Nigeria: A Case–Control Study by Esther A. Ekwe, Birinus A. Ezeala-Adikaibe, Basden Onwubere, Julius Okoye, Collins Ugwu, Chidinma B. Nwatu, Ijoma Chinweuba, Chidimma Orah-Okpala, Raphael Anakwue, Oladipupo O. Fasa, Celestine C. Okwara, Uchechi Q. Arinze, Paschal Njoku

    Published 2024-07-01
    “…Background: Although highly active antiretroviral therapy (HAART) has improved immunologic and virologic outcomes, as well as the quality of life of human immunodeficiency virus (HIV)-positive patients, it has worsened a wide range of metabolic derangements associated with HIV/AIDS. …”
    Get full text
    Article
  5. 245

    Free circulating ICAM-1 in serum and cerebrospinal fluid of HIV-1 infected patients correlate with TNF-α and blood-brain barrier damage by M. K. Sharief, M. Ciardi, M. A. Noori, E. J. Thompson, A. Salotti, F. Sorice, F. Rossi, A. Cirelli

    Published 1992-01-01
    “…The mechanism for the initiation of blood-brain barrier damage and intrathecal inflammation in patients infected with the human immunodeficiency virus (HIV) is poorly understood. We have recently reported that tumour necrosis factor-α (TNF-α) mediates active neural inflammation and blood-brain barrier damage in HIV-1 infection. …”
    Get full text
    Article
  6. 246

    Prevalence of HDV, HCV, and HIV Infection in the Population of Patients Infected with HBV in a Romanian Cohort by Antoanela Curici, Olivia Mioara Ilie, Dana Elena Mindru

    Published 2025-01-01
    “…This study aimed to assess the prevalence of hepatitis B virus (HBV), hepatitis delta virus (HDV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) co-infections in a cohort of 426,528 patients tested for HBsAg in Romania between 2018 and 2023. …”
    Get full text
    Article
  7. 247

    Children with HIV: A scoping review of auditory processing skills. by Gouwa Dawood, Daleen Klop, Elrietha Olivier, Haley Elliott, Mershen Pillay

    Published 2019-01-01
    “…They can result from a number of aetiologies, including the human immunodeficiency virus (HIV). Although studies in paediatrics are limited, research suggests that HIV-infected children display poorer auditory processing skills than uninfected children.…”
    Get full text
    Article
  8. 248

    The Potential Use of the CRISPR-Cas System for HIV-1 Gene Therapy by Gabriela De Nardi Sanches-da-Silva, Luiza Fonseca Sales Medeiros, Fabio Mitsuo Lima

    Published 2019-01-01
    “…The HIV-1 virus (human immunodeficiency virus) affects 36.9 million people worldwide, with approximately 900000 deaths in 2017. …”
    Get full text
    Article
  9. 249

    Prevention of Mother-to-Child HIV Transmission Service Utilization among Pregnant Women in Northeast Ethiopia: A Cross-Sectional Survey by Betregiorgis Zegeye, Gorems Lemma, Abebe Balcha, Mitku Mammo Taderegew

    Published 2020-01-01
    “…Targeting pregnant women attending antenatal care clinics provides a unique opportunity for implementing the Prevention of Mother-to-Child Transmission (PMTCT) programs against human immunodeficiency virus (HIV) infection of newborn babies. …”
    Get full text
    Article
  10. 250

    PD-1 Blockade in Advanced Melanoma in Patients with Hepatitis C and/or HIV by Diwakar Davar, Melissa Wilson, Chelsea Pruckner, John M. Kirkwood

    Published 2015-01-01
    “…Given hypothesized risk of triggering exacerbations of autoimmune diseases and/or chronic viral infections, clinical trials (including regulatory studies) evaluating checkpoint blocking antibodies PD-1 and CTLA-4 have excluded patients with autoimmune diseases, chronic hepatitis B/C virus (HBV/HCV), and/or human immunodeficiency virus (HIV) infections. Herein, we describe two patients with advanced melanoma and concomitant HCV/HIV infections treated with PD-1 inhibitor pembrolizumab. …”
    Get full text
    Article
  11. 251

    Worldwide Prevalence of Occupational Exposure to Needle Stick Injury among Healthcare Workers: A Systematic Review and Meta-Analysis by Dechasa Adare Mengistu, Sina Temesgen Tolera, Yohannes Mulugeta Demmu

    Published 2021-01-01
    “…Occupational exposure to needle stick injury represents the most common sources of infection such as hepatitis B virus, hepatitis C virus, and human immunodeficiency virus. Thus, this review aimed to determine the career time and previous one-year global pooled prevalence of occupational exposure to needle stick injury among healthcare workers. …”
    Get full text
    Article
  12. 252

    Effects of Undernutrition and Predictors on the Survival Status of HIV-Positive Children after Started Antiretroviral Therapy (ART) in Northwest Ethiopia by Mulugeta Molla, Fassikaw Kebede, Tsehay Kebede, Assefa Haile

    Published 2022-01-01
    “…Malnutrition and human immunodeficiency virus/acquired immunodeficiency syndrome have complex and multidirectional relationships. …”
    Get full text
    Article
  13. 253

    Quality of Life Patients HIV Based on Characteristic, Duration of Diagnosis, and Types Antiretroviral (ARV) by Iftikar Salma Amelia, Laili Rahayuwati, Hasniatisari Harun, Kusman Ibrahim, Ayu Prawesti, Iqbal Pramukti

    Published 2024-04-01
    “…Human Immunodeficiency Virus (HIV) is a retrovirus that attacks the body's immune system, leading to an increase in morbidity and mortality rates in Indonesia. …”
    Get full text
    Article
  14. 254

    Clinico- Therapeutic Study of Stevens Johnson Syndrome-Toxic Epidermal Necrolysis and Prognostic Significance of SCORTEN in Indian Patients by Neha Chetan Jangid, Ankita Nirmal Choudhary, Bela Jashwantlal Shah, Shikha Rupalkumar Shah, Harshita R Vyas, Deval Mistry

    Published 2024-01-01
    “…Comorbidities were observed in 60% of cases, with epilepsy (17.5%) and HIV (human immunodeficiency virus) infection (12.5%) being common. …”
    Get full text
    Article
  15. 255

    Effectiveness of nurse-led multi-component intervention program (NLMIP) on improving antiretroviral therapy adherence, CD4 count, psychological distress, and quality of life of peo... by Gulati Sonia, Pandurangan Hariprasath, Gupta P. Kumar

    Published 2025-01-01
    “…Background: Before the beginning of antiretroviral therapy (ART), human immunodeficiency virus (HIV)-positive patients require education. …”
    Get full text
    Article
  16. 256

    Atypical Kaposi Sarcoma of the Tongue in HIV Positive Tanzanian Female by Elichilia Shao, Flora Ruhangisa, Neema Minja, Kanankira Nnko, Denis Katundu, George Semango, Eva Mbwilo, Amos Mwasamwaja, Kajiru Kilonzo, Isaack Lyaruu

    Published 2015-01-01
    “…We report atypical case of Kaposi Sarcoma (KS) in a 32-year-old human immunodeficiency virus- (HIV-) infected female, involving only the tongue. …”
    Get full text
    Article
  17. 257

    Knowledge, Attitude, and Practice of Postexposure Prophylaxis against HIV Infection among Healthcare Workers in Hiwot Fana Specialized University Hospital, Eastern Ethiopia by Endalkachew Mekonnen Eticha, Ashenafi Beru Gemeda

    Published 2019-01-01
    “…Postexposure chemoprophylaxis can prevent human immunodeficiency virus (HIV) infection in risk health care workers; however routine adoption of these practices by the workers has been limited. …”
    Get full text
    Article
  18. 258

    Tuberculous Osteomyelitis of the Scapular Spine Revealing HIV-1 Infection by Khaoula Idsaid, Malika Idalene, Khadija Danaoui, Wiam Ait Driss, Rania Elfargani, Nabila Soraa, Noura Tassi

    Published 2024-12-01
    “…The subtle clinical manifestation and association with human immunodeficiency virus infection poses obstacles for early diagnosis and management. …”
    Get full text
    Article
  19. 259

    Medical Cannabis for Chronic Noncancer Pain: A Systematic Review of Health Care Recommendations by Yaping Chang, Meng Zhu, Christopher Vannabouathong, Raman Mundi, Roland S. Chou, Mohit Bhandari

    Published 2021-01-01
    “…All the included publications provided a recommendation supporting medical cannabis for CNCP in general and for the specific conditions of neuropathic pain, chronic pain in people living with Human Immunodeficiency Virus (HIV), and chronic abdominal pain, with detailed information sharing and comprehensive consideration of a patient’s own values and preferences. …”
    Get full text
    Article
  20. 260

    Modern vaccines and coronavirus infections by Yu. A. Belikova, Yu. V. Samsonov, E. V. Abakushina

    Published 2020-12-01
    “…It is clear that improvements are necessary to enable the development of successful vaccines against some difficult pathogens, including human immunodeficiency virus and hepatitis C virus. This review is on recent advances in the development of new generation vaccines, as well as those developed using earlier time-tested technologies: live attenuated vaccines, inactivated vaccines, recombinant vaccines, subunit vaccines, virus-like particle-based vaccines, synthetic peptide vaccines, DNA vaccines and mRNA vaccines. …”
    Get full text
    Article